Tag: AFRICA CDC

Africa’s Cholera Crisis Demands Continental Action

Michael Gwarisa

By Michael Gwarisa Africa is currently battling five major infectious disease outbreaks: Mpox, Measles, Dengue, Lassa Fever, and Cholera. Among these, Cholera has emerged as the deadliest, quietly eclipsing the rest in scale and lethality. Yet, despite its heavy toll, it remains under-prioritized. In 2024, the Africa Centres for Disease Control and Prevention (Africa CDC) declared Mpox a Public Health Emergency of Continental Security (PHECS), a bold step triggered by its rapid transmission across the Democratic Republic of Congo (DRC), Sierra Leone, and Uganda. That response was swift and strategic,…

Read More

Africa Faces 95% Mpox Vaccine Gap Amid Delayed Global Support

Michael Gwarisa

By Michael Gwarisa Africa is facing a critical shortfall in Mpox vaccine supply, with only 219,000 doses available out of the 6.4 million needed by August 2025 — a gap of more than 95%, according to the Africa Centres for Disease Control and Prevention (Africa CDC). Despite the World Health Organization (WHO) declaring Mpox a Public Health Emergency of International Concern in 2022, vaccine access across the continent remains alarmingly low, raising concerns of a repeat of the COVID-19 vaccine inequity crisis. Dr. Ngashi Ngongo, Chief Advisor to the Africa…

Read More

Africa CDC and Unitaid partner to strengthen equitable access to health products in Africa

Michael Gwarisa

By Staff Reporter The Africa Centres for Disease Control and Prevention (Africa CDC) and Unitaid have formed a new strategic partnership to expand the production of essential health products in Africa and improve sustainable access to medicines, diagnostics, and medical oxygen across the continent. Signed on the margins of the 78th World Health Assembly, the Memorandum of Understanding focuses on scaling up regional manufacturing as a central pillar of Africa’s health security and autonomy. Africa bears 25% of the global disease burden yet imports more than 95% of the active pharmaceutical…

Read More

Africa Accelerates Genomic Science to Tackle Epidemic Threats

Michael Gwarisa

By Michael Gwarisa in Addis Ababa Africa is increasingly becoming the frontline of global disease outbreaks. According to data from the Africa Centres for Disease Control and Prevention (Africa CDC), the continent recorded a 40% increase in outbreaks, from 152 in 2022 to 213 in 2024. In the past year alone, Africa has battled multiple health threats, including a deadly cholera outbreak in Southern Africa, escalating cases of Mpox in Central and East Africa, and Marburg and Ebola outbreaks in Rwanda, Tanzania, and Uganda respectively. While many of these outbreaks…

Read More

Africa CDC to Convene Emergency Meeting to Review Mpox Public Health Status

Michael Gwarisa

By Michael Gwarisa Following a sustained decline in reported Mpox cases across Africa, the Africa Centres for Disease Control and Prevention (Africa CDC) is set to convene an Emergency Consultative Group (ECG) meeting with experts to determine whether Mpox should still be classified as a public health emergency. In August 2024, Africa CDC declared Mpox a Public Health Emergency of Continental Security (PHECS)—the first such declaration since the agency’s inception in 2017. However, recent evidence from contact tracing and screening interventions suggests a notable reduction in Mpox-related morbidity and mortality…

Read More

Africa CDC to Convene Emergency Meeting to Review Mpox Public Health Status

Michael Gwarisa

By Michael Gwarisa Following a sustained decline in reported Mpox cases across Africa, the Africa Centres for Disease Control and Prevention (Africa CDC) is set to convene an Emergency Consultative Group (ECG) meeting with experts to determine whether Mpox should still be classified as a public health emergency. In August 2024, Africa CDC declared Mpox a Public Health Emergency of Continental Security (PHECS)—the first such declaration since the agency’s inception in 2017. However, recent evidence from contact tracing and screening interventions suggests a notable reduction in Mpox-related morbidity and mortality…

Read More

Rampant Sexual Networks Hinder Mpox Response in Africa

Michael Gwarisa

By Michael Gwarisa Efforts to curb the spread of Mpox among African Union member states remain a challenge due to widespread and interconnected sexual networks, HealthTimes has learned. Uganda currently leads in new Mpox cases, accounting for 50% of all recorded infections in Africa over the past six weeks. The majority of cases in Uganda stem from the Clade 1B strain, which is sexually transmitted. Uganda, Burundi, and the Democratic Republic of Congo (DRC) have collectively recorded 94% of confirmed cases since the beginning of the year. Speaking during the…

Read More

Africa CDC Hosts Mental Health Leadership Program In Harare to Address Growing Crisis in Africa

Michael Gwarisa

By Michael Gwarisa A 10-day Mental Health Leadership Program has kicked off in Harare, Zimbabwe, amid growing calls for governments to prioritize mental health as a public health emergency, HealthTimes has learned. The training program, aimed at equipping leaders from various sectors with the necessary skills and capacity to address the growing burden of mental health-related challenges on the continent, is being hosted by the University of Zimbabwe in collaboration with the  Africa Centres for Disease Control (Africa CDC). The programme is supported by Wellcome Trust and will run from…

Read More

Africa CDC Confirms Mpox Vaccine Production to Start in 2025

Michael Gwarisa

By Michael Gwarisa The Director-General of the Africa Centre for Disease Control (Africa CDC), Dr. Jean Kaseya, told a media briefing that local production of the Mpox vaccine on the continent will commence this year, although he did not provide specific timelines. In 2024, Africa CDC partnered with Bavarian Nordic to enhance vaccine manufacturing capabilities within Africa. The partnership aims to strengthen health security across the continent. We have the outcome; we have now started discussions with the successful bidders,” said Dr. Kaseya. “At the moment, we are finalizing some…

Read More

Amref CEO Warns US Withdrawal from WHO Could Leave Africa Exposed to Health Crises

Michael Gwarisa

By Michael Gwarisa Amref Health Africa Group CEO, Dr. Githinji Gitahi, has raised concerns over the decision by U.S. President Donald Trump to halt funding for the World Health Organization (WHO). Dr. Gitahi warns that the move could severely impact global health initiatives, leaving Africa particularly exposed. President Trump justified the U.S. withdrawal by criticizing WHO’s handling of the COVID-19 pandemic and other global health crises. As part of the decision, the U.S. plans to cease all financial contributions and formally exit WHO within 12 months. The United States has…

Read More